[[2-Bromo-4-[(2S)-3-(methylamino)-2-[(methylsulfonyl)amino]-3-oxopropyl]phenyl]difluoromethyl]-phosphonic Acid is used as a treatment for Rett syndrome by inhibiting protein tyrosine phosphatase 1B (PTP1B).
PROMPT×
PROMPT
The What'sApp is temporarily not supported in mainland China
